如何分流HPV阳性病例:四百万女性筛查结果
结果显示HPV DNA阳性率为4.39%,最常见型别为16型;现行筛查策略对≥CIN2的总体PPV为24.3%,仅Pap-smear分流在≥ASC-US阈值下PPV为26.4%。结论认为单次就诊筛查分流模式在发展中国家可行,且仅Pap-smear分流有效,无需扩展基因分型。
要点
- HPV DNA阳性率4.39%,最常见型别依次为16、51、31、52、56和18。
- 现行筛查策略对≥CIN2的总体PPV为24.3%。
- 仅Pap-smear分流在≥ASC-US阈值下PPV为26.4%,无需扩展基因分型。
核心结论
- 单次就诊HPV DNA筛查联合分流模式在发展中国家可行且阴道镜转诊率可接受。
- 分流检测中仅Pap-smear有效,无需扩展基因分型。
研究设计与样本
- 基于土耳其全国HPV DNA筛查项目首批4,099,230名30岁以上女性的真实世界数据。
- 采用单次就诊筛查策略,同时采集HPV DNA检测和传统细胞学(含扩展基因分型)用于分流。
主要发现
- HPV DNA阳性率为4.39%。
- 最常见HPV型别为16,其次为51、31、52、56和18,在各年龄区间和地理区域均如此。
- 细胞学结果正常占69.2%,采样不足占16.6%,异常(≥ASC-US)占剩余部分。
- 现行筛查策略(HPV 16或18阳性或任何细胞学异常≥ASC-US转诊阴道镜)对≥CIN2的总体PPV为24.3%。
- 仅Pap-smear分流在≥ASC-US阈值下PPV为26.4%。
关键数值与推荐
- HPV 33、31、45和35的PPV分别为34.4%、19.3%、15.3%和14.0%。
临床怎么用
- 在资源有限地区可采用单次就诊HPV DNA筛查联合Pap-smear分流。
- 分流时仅用Pap-smear即可,无需扩展基因分型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the Turkey's nationwide HPV DNA screening program on the basis of first 4 million screened women. METHODS: Women over age 30 were invited for screening via HPV DNA and conventional cytology. Single visit screen strategy was used to collect for both screening and triage (extended genotyping and conventional pap-smear). RESULTS: A total of 4,099,230 patients had attended to HPV DNA cancer screening. 4.39% were found to be HPV DNA positive. The most common HPV type was 16, followed by 51, 31, 52, 56 and 18 at all age intervals and geographic regions. Cytology results were reported as "normal" in (69.2%), "inadequate sampling" in (16.6%) and as "abnormal (≥ASC-US)" in the remaining. Current Turkish screening with HPV DNA (referral to colposcopy with HPV 16 or 18 or any smear abnormality ≥ASC-US) gives overall PPV of 24.3% for ≥CIN2. Only Pap-Smear triage revealed PPV of 26.4% for ≥ASC-US thresholds. Comparison of different triage methods for ≥CIN2+ according to different HPV genotype revealed a PPV of 32,6% for HPV 16; 15,3% for HPV 18. This figure was 34.4%, 19.3%, 15.3% and 14.0% for HPV 33, 31, 45 and 35; respectively. CONCLUSION: This study involves the largest series in the world summarizing a real-world experience with primary HPV DNA screening and triage with a single visit. The results show the feasibility and applicability of such screening method in developing countries with acceptable colposcopy referral rates. Among triage tests, only pap-smear seems to be effective without a need for extended genotyping.
引用
- Gultekin M, Dundar S, Keskinkilic B, et al. How to triage HPV positive cases: Results of four million females. Gynecol Oncol. 2020. PMID: 32362567. doi:10.1016/j.ygyno.2020.04.698
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。